Search Results - "Metcalf, Julia"

Refine Results
  1. 1

    Interleukin-15 (IL-15) Strongly Correlates with Increasing HIV-1 Viremia and Markers of Inflammation by Swaminathan, Sanjay, Qiu, Ju, Rupert, Adam W, Hu, Zonghui, Higgins, Jeanette, Dewar, Robin L, Stevens, Randy, Rehm, Catherine A, Metcalf, Julia A, Sherman, Brad T, Baseler, Michael W, Lane, H Clifford, Imamichi, Tomozumi

    Published in PloS one (23-11-2016)
    “…IL-15 has been postulated to play an important role in HIV-1 infection, yet there are conflicting reports regarding its expression levels in these patients. We…”
    Get full text
    Journal Article
  2. 2

    Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease by Ledwaba, Lotty, Tavel, Jorge A, Khabo, Paul, Maja, Patrick, Qin, Jing, Sangweni, Phumele, Liu, Xiao, Follmann, Dean, Metcalf, Julia A, Orsega, Susan, Baseler, Beth, Neaton, James D, Lane, H Clifford

    Published in PloS one (20-03-2012)
    “…Levels of high-sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6), and D-dimer predict mortality in HIV patients on antiretroviral therapy (ART) with…”
    Get full text
    Journal Article
  3. 3

    ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia by Maldarelli, Frank, Palmer, Sarah, King, Martin S, Wiegand, Ann, Polis, Michael A, Mican, JoAnn, Kovacs, Joseph A, Davey, Richard T, Rock-Kress, Diane, Dewar, Robin, Liu, Shuying, Metcalf, Julia A, Rehm, Catherine, Brun, Scott C, Hanna, George J, Kempf, Dale J, Coffin, John M, Mellors, John W

    Published in PLoS pathogens (01-04-2007)
    “…Current antiretroviral therapy is effective in suppressing but not eliminating HIV-1 infection. Understanding the source of viral persistence is essential for…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The benefit of immediate compared with deferred antiretroviral therapy on CD4+ cell count recovery in early HIV infection by Sharma, Shweta, Schlusser, Katherine E, de la Torre, Pola, Tambussi, Giuseppe, Draenert, Rika, Pinto, Angie N, Metcalf, Julia A, Neaton, James D, Laeyendecker, Oliver

    Published in AIDS (London) (01-07-2019)
    “…OBJECTIVE:To assess the impact of immediate vs. deferred antiretroviral therapy (ART) on CD4 recovery among individuals early in HIV infection. DESIGN:Using…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors by Zonios, Dimitrios I., Falloon, Judith, Bennett, John E., Shaw, Pamela A., Chaitt, Doreen, Baseler, Michael W., Adelsberger, Joseph W., Metcalf, Julia A., Polis, Michael A., Kovacs, Stephen J., Kovacs, Joseph A., Davey, Richard T., Lane, H. Clifford, Masur, Henry, Sereti, Irini

    Published in Blood (15-07-2008)
    “…Idiopathic CD4+ lymphocytopenia (ICL) is a rare non–HIV-related syndrome with unclear natural history and prognosis. This prospective natural history cohort…”
    Get full text
    Journal Article
  9. 9

    The effects of storage temperature on PBMC gene expression by Yang, Jun, Diaz, Norma, Adelsberger, Joseph, Zhou, Xueyuan, Stevens, Randy, Rupert, Adam, Metcalf, Julia A, Baseler, Mike, Barbon, Christine, Imamichi, Tomozumi, Lempicki, Richard, Cosentino, Louis M

    Published in BMC immunology (15-03-2016)
    “…Cryopreservation of peripheral blood mononuclear cells (PBMCs) is a common and essential practice in conducting research. There are different reports in the…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Plasma interleukin-27 (IL-27) levels are not modulated in patients with chronic HIV-1 infection by Swaminathan, Sanjay, Hu, Zonghui, Rupert, Adam W, Higgins, Jeanette M, Dewar, Robin L, Stevens, Randy, Chen, Qian, Rehm, Catherine A, Metcalf, Julia A, Baseler, Michael W, Lane, H Clifford, Imamichi, Tomozumi

    Published in PloS one (04-06-2014)
    “…IL-27 is an immunomodulatory cytokine with potent anti-HIV properties in PBMCs, CD4+ T cells, macrophages and immature dendritic cells. Previous smaller…”
    Get full text
    Journal Article
  13. 13

    Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial by Baker, Jason V, Sharma, Shweta, Grund, Birgit, Rupert, Adam, Metcalf, Julia A, Schechter, Mauro, Munderi, Paula, Aho, Inka, Emery, Sean, Babiker, Abdel, Phillips, Andrew, Lundgren, Jens D, Neaton, James D, Lane, H Clifford

    Published in Open forum infectious diseases (2017)
    “…Abstract Background The Strategic Timing of AntiRetroviral Treatment (START) trial demonstrated that immediate (at CD4+ >500 cells/µL) vs deferred (to CD4+…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Comparison of Self-report to Biomarkers of Recent HIV Infection: Findings from the START Trial by Schlusser, Katherine E., Sharma, Shweta, de la Torre, Pola, Tambussi, Giuseppe, Draenert, Rika, Pinto, Angie N., Metcalf, Julia A., German, Danielle, Neaton, James D., Laeyendecker, Oliver

    Published in AIDS and behavior (01-07-2018)
    “…Identifying individuals with recent HIV infection is critical to research related to viral reservoirs, outbreak investigations and intervention applications. A…”
    Get full text
    Journal Article
  16. 16
  17. 17

    HIV-1 infected monozygotic twins: a tale of two outcomes by Tazi, Loubna, Imamichi, Hiromi, Hirschfeld, Steven, Metcalf, Julia A, Orsega, Susan, Pérez-Losada, Marcos, Posada, David, Lane, H Clifford, Crandall, Keith A

    Published in BMC evolutionary biology (08-03-2011)
    “…Replicate experiments are often difficult to find in evolutionary biology, as this field is inherently an historical science. However, viruses, bacteria and…”
    Get full text
    Journal Article
  18. 18

    Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa by KOMATI, Stephanus, SHAW, Pamela A, STUBBS, Nomso, MATHIBEDI, Monkwe J, MALAN, Lizette, SANGWENI, Phumelele, METCALF, Julia A, MASUR, Henry, HASSIM, Shaheen

    Published in AIDS (London) (31-07-2010)
    “…To determine important risk factors for and impact of tuberculosis on survival in HIV-infected patients starting antiretroviral therapy (ART) in South Africa…”
    Get full text
    Journal Article
  19. 19
  20. 20